MeSH Browser

MeSH Supplementary: brexucabtagene autoleucel
Unique ID: C000705347
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000705347
Entry Term(s): KTE-X19
Pharm Action: Antineoplastic Agents, Immunological
Registry Numbers: 4MD2J2T8SJ
Heading Mapped to: *Immunotherapy, Adoptive; *Receptors, Chimeric Antigen
Frequency: 19
Note: an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for patients with relapsed or refractory mantle-cell lymphoma
Source: N Engl J Med. 2020 Apr 2;382(14):1331-1342.
Date of Entry: 2020/04/10
Revision Date: 2021/11/05

brexucabtagene autoleucel MeSH Supplementary Concept Data 2025